PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsParathyroid neoplasms
MeSH D010282 - parathyroid neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006258:Head and neck neoplasms
57 Companies
8 Drugs
$
Success rate
D004701:Endocrine gland neoplasms
0 Companies
0 Drugs
Success rate
D010279:Parathyroid diseases
0 Companies
0 Drugs
Success rate
D010282: 
Parathyroid neoplasms
16 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Rising PharmaceuticalsCinacalcet Cinacalcet  2018-10-16   
MylanCinacalcet Cinacalcet Mylan  2015-11-19   
CiplaCinacalcet Cinacalcet  2018-03-08   
Lupin ResearchCinacalcet Cinacalcet  2019-06-28   
Aurobindo PharmaCinacalcet Cinacalcet  2018-03-08   
Dr Reddys LaboratoriesCinacalcet Cinacalcet  2020-09-18   
Sun Pharmaceutical IndustriesCinacalcet Cinacalcet  2018-10-11   
Alkem LaboratoriesCinacalcet Cinacalcet  2019-05-17   
HeteroCinacalcet Cinacalcet  2020-10-07   
Jerome Stevens PharmaceuticalsCinacalcet Cinacalcet  2021-12-02   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
22%
2/9
Phase 2
17%
1/6
Phase 3
60%
3/5
Approved: 2Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Amgen
Cinacalcet,
Bevifimod,
Globulin, immune
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use